BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Psychiatry. Apr 19, 2026; 16(4): 111713
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.111713
Table 1 Baseline clinical characteristics of the study cohort, n (%)/mean ± SD
Data
n = 306
Sex
Male160 (52.29)
Female146 (47.71)
Age (years)9.96 ± 1.38
Illness duration (day)5.10 ± 2.13
Disease severity
Mild171 (55.88)
Moderate135 (44.12)
DSRSC (points)14.92 ± 4.33
≤ 15173 (56.54)
> 15133 (43.46)
SCARED (points)22.89 ± 5.89
≤ 23174 (56.86)
> 23132 (43.14)
Table 2 Differences in emotional states among pediatric bronchopneumonia patients by clinical features, mean ± SD
Variable
DSRSC (points)
t value
P value
SCARED (points)
t value
P value
Sex0.7870.4320.3110.756
Male (n = 160)14.73 ± 4.1722.99 ± 6.27
Female (n = 146)15.12 ± 4.5022.78 ± 5.45
Age (years)0.9750.3300.1020.919
≤ 10 (n = 127)14.63 ± 4.2322.93 ± 6.09
> 10 (n = 179)15.12 ± 4.4022.86 ± 5.75
Illness duration (day)2.0160.0456.921< 0.001
≤ 4 (n = 129)13.22 ± 3.9820.35 ± 5.19
> 4 (n = 177)16.15 ± 4.1624.74 ± 5.68
Disease severity4.050< 0.0014.784< 0.001
Mild (n = 171)14.05 ± 4.3221.51 ± 5.70
Moderate (n = 135)16.02 ± 4.1024.64 ± 5.66
Table 3 Relationship between depression and treatment compliance in pediatric bronchopneumonia patients, n (%)
Treatment compliance
Depression group (n = 133)
Non-depression group (n = 173)
χ2 value
P value
Complete compliance58 (43.61)95 (54.91)
Partial compliance57 (42.86)70 (40.46)
Non-compliance18 (13.53)8 (4.62)
Total compliance115 (86.47)165 (95.38)7.6770.006
Table 4 Association of anxiety with treatment compliance in pediatric bronchopneumonia patients, n (%)
Treatment compliance
Anxiety group (n = 132)
Non-anxiety group (n = 174)
χ2 value
P value
Complete compliance55 (41.67)98 (56.32)
Partial compliance61 (46.21)66 (37.93)
Non-compliance16 (12.12)10 (5.75)
Total compliance116 (87.88)164 (94.25)3.9220.048